ARCHIVES

Budget Difficulties Aside, Centers Important To NCI, Broder Asserts; Warns Against Sabotage.

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

NS Sponsors Workshop On Prevention For Three Minority Groups

July 1, 1988

In Congress: Varmus Defends Raise In Cancer Funding; Porter Says Allocation Difficult If No Agreement On Tobacco Legislation

March 13, 1998

Funding Opportunities: Lymphoma Foundation Offers Two-Year Fellowship Grants

July 31, 1998

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010